{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:32:27Z","timestamp":1781645547362,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jhep.2012.02.021","type":"journal-article","created":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T06:53:19Z","timestamp":1331621599000},"page":"61-68","source":"Crossref","is-referenced-by-count":22,"title":["Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice"],"prefix":"10.1016","volume":"57","author":[{"given":"Femke","family":"Heindryckx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kuchnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Casteleyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Coulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Olievier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Colle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Geerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Libbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Carmeliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2012.02.021_b0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","article-title":"Angiogenesis in chronic liver disease and its complications","volume":"31","author":"Coulon","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2012.02.021_b0010","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.107.701516","article-title":"Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system","volume":"116","author":"Takeda","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2012.02.021_b0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ccr.2009.04.010","article-title":"Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment","volume":"15","author":"Chan","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2012.02.021_b0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/0008-5472.CAN-09-1876","article-title":"Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors","volume":"70","author":"Henze","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2012.02.021_b0025","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","article-title":"Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization","volume":"136","author":"Mazzone","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2012.02.021_b0170","article-title":"Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer","author":"Su","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2012.02.021_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6605682","article-title":"PHD2 in tumor angiogenesis","volume":"103","author":"Chan","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2012.02.021_b0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1476-4598-9-219","article-title":"Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma","volume":"9","author":"Heindryckx","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jhep.2012.02.021_b0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2010.02.039","article-title":"Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease","volume":"141","author":"Van de Veire","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2012.02.021_b0175","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.gastro.2011.03.044","article-title":"A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression","volume":"141","author":"Yang","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.02.021_b0055","doi-asserted-by":"crossref","first-page":"11536","DOI":"10.1158\/0008-5472.CAN-07-1479","article-title":"Hepatocellular carcinoma associated with liver-gender disruption in male mice","volume":"67","author":"Rogers","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2012.02.021_b0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0168-8278(98)80318-8","article-title":"Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers","volume":"28","author":"Pilette","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.02.021_b0065","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/hep.24238","article-title":"Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice","volume":"53","author":"Van Steenkiste","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.021_b0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/gut.2009.188367","article-title":"Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling","volume":"59","author":"Spee","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2012.02.021_b0075","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1158\/0008-5472.CAN-09-2823","article-title":"Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma","volume":"70","author":"Woo","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2012.02.021_b0185","article-title":"SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma","author":"El-Khoueiry","year":"2011","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jhep.2012.02.021_b0085","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1158\/1541-7786.MCR-07-2113","article-title":"The biphasic role of the hypoxia-inducible factor prolyl-4-hydroxylase, PHD2, in modulating tumor-forming potential","volume":"6","author":"Lee","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jhep.2012.02.021_b0090","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1641\/0006-3568(2003)053[1112:BSAEPO]2.0.CO;2","article-title":"Biological stoichiometry: an ecological perspective on tumor dynamics","volume":"53","author":"Elser","year":"2003","journal-title":"Bioscience"},{"key":"10.1016\/j.jhep.2012.02.021_b0095","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/hep.510280610","article-title":"Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma","volume":"28","author":"Kawahara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.021_b0100","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ccr.2011.05.007","article-title":"Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia","volume":"19","author":"Schmidt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2012.02.021_b0105","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1158\/0008-5472.CAN-10-3838","article-title":"Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFbeta","volume":"71","author":"Ameln","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2012.02.021_b0110","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1158\/1078-0432.CCR-10-1360","article-title":"Hypoxia and hypoxia-inducible factors: master regulators of metastasis","volume":"16","author":"Lu","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2012.02.021_b0115","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1016\/S1590-8658(10)60510-5","article-title":"Histopathological classification of hepatocellular carcinoma","volume":"42","author":"Roncalli","year":"2010","journal-title":"Digest Liver Dis"},{"key":"10.1016\/j.jhep.2012.02.021_b0120","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1038\/sj.onc.1209558","article-title":"Liver stem cells and their implication in hepatocellular and cholangiocarcinoma","volume":"25","author":"Roskams","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2012.02.021_b0125","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/carcin\/16.4.845","article-title":"The resistant hepatocyte model of carcinogenesis in the rat: the apparent independent development of oval cell proliferation and early nodules","volume":"16","author":"Anilkumar","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhep.2012.02.021_b0130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/jhep.2002.35540","article-title":"Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats","volume":"36","author":"Bralet","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.021_b0135","first-page":"391","article-title":"Notch signaling dependent differentiation of cholangiocyte-like cells from rhesus monkey embryonic stem cells","volume":"32","author":"Jin","year":"2011","journal-title":"Zoo Res"},{"key":"10.1016\/j.jhep.2012.02.021_b0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jhep.2004.10.025","article-title":"Adaptative bile duct proliferative response in experimental bile duct ischemia","volume":"42","author":"Beaussier","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.02.021_b0145","first-page":"G25","article-title":"Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes","volume":"293","author":"Fouassier","year":"2007","journal-title":"AMJ Phys"},{"key":"10.1016\/j.jhep.2012.02.021_b0150","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/lt.22307","article-title":"Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma","volume":"17","author":"Sapisochin","year":"2011","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jhep.2012.02.021_b0155","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/lt.22314","article-title":"Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation","volume":"17","author":"Zen","year":"2011","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jhep.2012.02.021_b0160","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"Paez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2012.02.021_b0165","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/labinvest.2010.161","article-title":"Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma","volume":"91","author":"Yoneda","year":"2011","journal-title":"Lab Invest"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812002085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812002085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T09:59:04Z","timestamp":1543139944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827812002085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0168827812002085"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2012.02.021","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}